Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.


A software development company that produce clinical trial data. In 2005 Third Phase Ltd merged with the Cmed Group Ltd. Third Phase Limited Merges with Cmed Group October 2005.

Incorporated in January 2000

Origin: Oxford University, Engineering


Image analysis.

Incorporated in December 1999

Origin: Oxford University, Gray Institute for Radiation Oncology & Biology

Sensor development.

Incorporated in August 1999

Origin: Oxford University, Nuffield Department of Anaesthetics

Parallel hardware/software design.

Incorporated in June 1999

Origin: Oxford University, Maths


Pharmaceutical services. In 2009 Sense Proteomics Ltd was acquired by Oxford Gene Technology (OGT).

Incorporated in November 1998

Origin: Oxford University


Incorporated in June 1998

Origin: Oxford University, Pathology

Neurodegenerative diseases.

Incorporated in March 1998

Origin: Oxford University, Pathology




Drug/Vaccine Delivery.

Incorporated in October 1994

Origin: Oxford University


Drug Development. Oxford Asymmetry merges with Evotec BioSystems April 2009.

Incorporated in April 1992

Origin: Oxford University, Chemistry


Chemical information management.

Incorporated in August 1989

Origin: Oxford University, Chemistry



Incorporated in September 1988

Origin: Oxford University, Chemistry

Ready to get in touch?

Contact Us
© Oxford University Innovation